President Joe Biden delivers remarks on healthcare costs at the White House on April 3, 2024 (Mark Schiefelbein/AP Images)
April 3, 2024 01:12 PM EDTUpdated 02:14 PM
Pharma
FDA+

'We beat big phar­ma': Biden ap­plauds IRA, calls for ex­pan­sion of Medicare ne­go­ti­a­tions

Nicole DeFeudis

Editor

Pres­i­dent Joe Biden re­newed his pro­pos­al to ex­pand drug price ne­go­ti­a­tions un­der the In­fla­tion Re­duc­tion Act on Wednes­day, ar­gu­ing that “we should be more ag­gres­sive …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Chi­nese drug­mak­er re­ceives FDA warn­ing let­ter af­ter man­age­ment hin­dered in­spec­tion

GSK plots reg­u­la­to­ry fil­ings for PBC itch af­ter pos­i­tive Phase 3 read­out

Bio­gen, UCB de­tail re­sponse rates in Phase 3 lu­pus tri­al af­ter sur­pris­ing suc­cess

J&J, Pro­tag­o­nist re­veal two Phase 3 wins for oral IL-23 drug that's ex­pect­ed to be a block­buster

Law­mak­ers are pok­ing holes in phar­ma's fa­vorite new way to mar­ket med­i­cines

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times